Adjunctive glucocorticoid therapy in patients with septic shock.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Whether hydrocortisone reduces mortality among patients with septic shock is unclear. METHODS: We randomly assigned patients with septic shock who were undergoing mechanical ventilation to receive hydrocortisone (at a dose of 200 mg per day) or placebo for 7 days or until death or discharge from the intensive care unit (ICU), whichever came first. The primary outcome was death from any cause at 90 days. RESULTS: From March 2013 through April 2017, a total of 3800 patients underwent randomization. Status with respect to the primary outcome was ascertained in 3658 patients (1832 of whom had been assigned to the hydrocortisone group and 1826 to the placebo group). At 90 days, 511 patients (27.9%) in the hydrocortisone group and 526 (28.8%) in the placebo group had died (odds ratio, 0.95; 95% confidence interval [CI], 0.82 to 1.10; P=0.50). The effect of the trial regimen was similar in six prespecified subgroups. Patients who had been assigned to receive hydrocortisone had faster resolution of shock than those assigned to the placebo group (median duration, 3 days [interquartile range, 2 to 5] vs. 4 days [interquartile range, 2 to 9]; hazard ratio, 1.32; 95% CI, 1.23 to 1.41; P<0.001). Patients in the hydrocortisone group had a shorter duration of the initial episode of mechanical ventilation than those in the placebo group (median, 6 days [interquartile range, 3 to 18] vs. 7 days [interquartile range, 3 to 24]; hazard ratio, 1.13; 95% CI, 1.05 to 1.22; P<0.001), but taking into account episodes of recurrence of ventilation, there were no significant differences in the number of days alive and free from mechanical ventilation. Fewer patients in the hydrocortisone group than in the placebo group received a blood transfusion (37.0% vs. 41.7%; odds ratio, 0.82; 95% CI, 0.72 to 0.94; P=0.004). There were no significant between-group differences with respect to mortality at 28 days, the rate of recurrence of shock, the number of days alive and out of the ICU, the number of days alive and out of the hospital, the recurrence of mechanical ventilation, the rate of renal-replacement therapy, and the incidence of new-onset bacteremia or fungemia. CONCLUSIONS: Among patients with septic shock undergoing mechanical ventilation, a continuous infusion of hydrocortisone did not result in lower 90-day mortality than placebo. (Funded by the National Health and Medical Research Council of Australia and others; ADRENAL ClinicalTrials.gov number, NCT01448109 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since then, three large RCTs have been published [354, 478, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The optimal dose, timing of initiation, and duration of corticosteroids remain uncertain; recent RCTs used 200 mg per day of IV hydrocortisone in divided doses [354, 479].”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“The three trials [354, 478, 479] also used different inclusion criteria: in ADRENAL [479] eligible patients were those on any dose of vasopressor or inotrope for ≥ 4 h to maintain a MAP > 60 mmHg, and present at the time of randomisation.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
In the citing paper
“In the ADRENAL [479] study, hydrocortisone was administered for a maximum of seven days or until ICU discharge or death; in APROCCHSS [478] hydrocortisone was administered for seven days; in VANISH [354] 200 mg of hydrocortisone was administered daily for 5 days and then tapered over further 6 days.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [479]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Self-citationA Simple Sequentially Rejective Multiple Test Procedure
(1979) · Scandinavian Journal of Statistics · doi:10.2307/4615733 · Cited by 21,526
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Self-citationFleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Hydrocortisone Therapy for Patients with Septic Shock
Sprung, C. L., Annane, D., Keh, D., Moreno, R., Singer, M., Freivogel, K., Weiss, Y. G., Benbenishty, J., Kalenka, A., Forst, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa071366 · Cited by 2,132
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., Balk, R. A., & The Methylprednisolone Severe Sepsis Study Group (1987) · New England Journal of Medicine · doi:10.1056/nejm198709103171101 · Cited by 1,440
Recognizing Sepsis as a Global Health Priority — A WHO Resolution
Reinhart, K., Daniels, R., Kissoon, N., Machado, F. R., Schachter, R. D., & Finfer, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmp1707170 · Cited by 1,356
Self-citationDrotrecogin Alfa (Activated) in Adults with Septic Shock
Ranieri, V. M., Thompson, B. T., Barie, P. S., Dhainaut, J.-F., Douglas, I. S., Finfer, S., Gårdlund, B., Marshall, J. C., Rhodes, A., Artigas, A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202290 · Cited by 1,309 · cited 2×
“‡ Scores on the Acute Physiology and Chronic Health Evaluation (APACHE) II are assessed on a scale from 0 to 71, with higher scores indicating a higher risk of death (a score of ≥25 has been used as a cutoff point to identify patients at a higher risk for death).(23-25) § The values for baseline therapies denote the v…”
MethodSelf-citationHospital Deaths in Patients With Sepsis From 2 Independent Cohorts
Liu, V., Escobar, G. J., Greene, J. D., Soule, J., Whippy, A., Angus, D. C., & Iwashyna, T. J. (2014) · JAMA · doi:10.1001/jama.2014.5804 · Cited by 977 · cited 3×
“The authors’ affiliations are as follows: the George Institute for Global Health, University of New South Wales (B.V., S.F., D.R., L.B., M.C., P.G., M.H., Q.L., K.T., J.M.), St. George Clinical School, St. George Hospital (J.M.), Sydney Medical School, University of Sydney (B.V., S.F., J.M.), and Royal North Shore Hos…”
BackgroundDrotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death
Abraham, E., Laterre, P.-F., Garg, R., Levy, H., Talwar, D., Trzaskoma, B. L., François, B., Guy, J. S., Brückmann, M., Rea-Neto, Á., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050935 · Cited by 890 · cited 2×
“‡ Scores on the Acute Physiology and Chronic Health Evaluation (APACHE) II are assessed on a scale from 0 to 71, with higher scores indicating a higher risk of death (a score of ≥25 has been used as a cutoff point to identify patients at a higher risk for death).(23-25) § The values for baseline therapies denote the v…”
MethodSprung, C. L., Caralis, P. V., Marcial, E. H., Pierce, M., Gelbard, M. A., Long, W. M., Duncan, R. C., Tendler, M. D., & Karpf, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198411013111801 · Cited by 765 · cited 6×
“Supported by project grants from the National Health and Medical Research Council of Australia (grant nos., 1004108 and 1124926) and the Health Research Council of New Zealand (grant no., 12/306), by indirect funding from the National Institute of Health Research in the United Kingdom, and by Practitioner Fellowships…”
BackgroundInfluentialKeh, D., Boehnke, T., Weber-Cartens, S., Schulz, C., Ahlers, O., Bercker, S., Volk, H.-D., Doecke, W.-D., Falke, K. J., & Gerlach, H. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200205-446oc · Cited by 600
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
Annane, D., Bellissant, E., Bollaert, P.-E., Briegel, J., Confalonieri, M., De Gaudio, R., Keh, D., Kupfer, Y., Oppert, M., & Meduri, G. U. (2009) · JAMA · doi:10.1001/jama.2009.815 · Cited by 561 · cited 3×
“Supported by project grants from the National Health and Medical Research Council of Australia (grant nos., 1004108 and 1124926) and the Health Research Council of New Zealand (grant no., 12/306), by indirect funding from the National Institute of Health Research in the United Kingdom, and by Practitioner Fellowships…”
BackgroundInhibition of Adrenal Steroidogenesis by the Anesthetic Etomidate
Wagner, R. L., White, P. F., Kan, P. B., Rosenthal, M. H., & Feldman, D. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405313102202 · Cited by 555
Steroids in the Treatment of Clinical Septic Shock
SCHUMER, W. (1976) · Annals of Surgery · doi:10.1097/00000658-197609000-00011 · Cited by 545
Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units
Finfer, S., Bellomo, R., Lipman, J., French, C., Dobb, G., & Myburgh, J. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2157-0 · Cited by 442
Self-citationMachado, F. R., Cavalcanti, A. B., Bozza, F. A., Ferreira, E. M., Angotti Carrara, F. S., Sousa, J. L., Caixeta, N., Salomao, R., Angus, D. C., Pontes Azevedo, L. C., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30322-5 · Cited by 416
Estimation of Multivariate Frailty Models Using Penalized Partial Likelihood
Ripatti, S., & Palmgren, J. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.01016.x · Cited by 398
A comparison of epinephrine and norepinephrine in critically ill patients
Myburgh, J. A., Higgins, A., Jovanovska, A., Lipman, J., Ramakrishnan, N., Santamaria, J., & the CAT Study investigators (2008) · Intensive Care Medicine · doi:10.1007/s00134-008-1219-0 · Cited by 368
Self-citationCorticosteroids for treating sepsis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub3 · Cited by 210
Age of Red Cells for Transfusion and Outcomes in Critically Ill Adults
Cooper, D. J., McQuilten, Z. K., Nichol, A., Ady, B., Aubron, C., Bailey, M., Bellomo, R., Gantner, D., Irving, D. O., Kaukonen, K.-M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707572 · Cited by 192
Self-citationHow to handle mortality when investigating length of hospital stay and time to clinical stability
Brock, G. N., Barnes, C., Ramirez, J. A., & Myers, J. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-144 · Cited by 138
Glucocorticosteroids for sepsis: systematic review with meta-analysis and trial sequential analysis
Volbeda, M., Wetterslev, J., Gluud, C. N., Zijlstra, J. G., van der Horst, I. C. C., & Keus, F. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3899-6 · Cited by 123
Venkatesh, B., Mortimer, R. H., Couchman, B. A., & Hall, J. (2005) · Anaesthesia and Intensive Care · doi:10.1177/0310057x0503300208 · Cited by 100
Self-citationLoisa, P., Parviainen, I., Tenhunen, J., Hovilehto, S., & Ruokonen, E. (2007) · Critical Care · doi:10.1186/cc5696 · Cited by 95
for the CORTICUS Study Group, Briegel, J., Sprung, C. L., Annane, D., Singer, M., Keh, D., Moreno, R., Möhnle, P., Weiss, Y., Avidan, A., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1627-9 · Cited by 93
Glucocorticoids in the treatment of severe sepsis and septic shock
Annane, D. (2005) · Current Opinion in Critical Care · doi:10.1097/01.ccx.0000176691.95562.43 · Cited by 91
Beale, R. J., Janes, J., Brunkhorst, F. M., DOBB, G. J., Levy, M. M., Martin, G. S., Ramsay, G., Silva, E., Sprung, C. L., Vallet, B., et al. (2010) · Critical Care · doi:10.1186/cc9044 · Cited by 85
Tight Glycemic Control in Critically Ill Patients—Reply
Annane, D. (2010) · JAMA · doi:10.1001/jama.2010.516 · Cited by 62
Venkatesh, B., Myburgh, J., Finfer, S. R., Webb, S. A. R., Cohen, J., Bellomo, R., McArthur, C. J., Joyce, C., Rajbhandari, D., Glass, P., et al. (2013) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)01786-6 · Cited by 61
Self-citationVenkatesh, B., & Cohen, J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12702 · Cited by 24
Self-citationTiming, method and discontinuation of hydrocortisone administration for septic shock patients
Ibarra-Estrada, M. Á., Chávez-Peña, Q., Reynoso-Estrella, C. I., Ríos-Zermeño, J., Aguilera-González, P. E., García-Soto, M. A., & Aguirre-Ávalos, G. (2017) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v6.i1.65 · Cited by 19
Rapid Nongenomic Effect of Corticosterone on Neuronal Nicotinic Acetylcholine Receptor in PC12 Cells
Shi, L., He, Y.-Y., Liu, L.-A., & Wang, C.-A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2519 · Cited by 18
Billot, L., Venkatesh, B., Myburgh, J., Finfer, S. R., Cohen, J., Webb, S. A. R., McArthur, C. J., Joyce, C., Bellomo, R., Rhodes, A., et al. (2017) · Critical Care and Resuscitation · doi:10.1016/s1441-2772(23)00791-3 · Cited by 11
Self-citation
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Self-citationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Self-citationPanchal, A. R., Bartos, J. A., Cabañas, J. G., Donnino, M. W., Drennan, I. R., Hirsch, K. G., Kudenchuk, P. J., Kurz, M. C., Lavonas, E. J., Morley, P. T., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000916 · Cited by 2,105
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,008
“21, 22 In this group, there is potential that net benefit might be derived from steroid treatment in severe shock.”
Topjian, A. A., Raymond, T. T., Atkins, D., Chan, M., Duff, J. P., Joyner, B. L., Lasa, J. J., Lavonas, E. J., Levy, A., Mahgoub, M., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000901 · Cited by 1,258
Metadata
- Authors
- Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., Joyce, C., Li, Q., McArthur, C., Perner, A., Rhodes, A., Thompson, K., Webb, S., & Myburgh, J.
- Affiliations
- The University of Sydney (AU)
- From the George Institute for Global Health, University of New South Wales (B.V., S.F., D.R., L.B., M.C., P.G., M.H., Q.L., K.T., J.M.), St. George Clinical School, St. George Hospital (J.M.), Sydney Medical School, University of Sydney (B.V., S.F., J.M.), and Royal North Shore Hospital (S.F.), Sydney, the Princess Alexandra Hospital (B.V., C.J.) and Royal Brisbane and Women’s Hospital (J.C.), University of Queensland, and the Wesley Hospital (B.V., J.C.), Brisbane, Austin Hospital (R.B.), the...
- University of Copenhagen (DK)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2018-03
- Volume
- 378
- Issue
- 9
- Pages
- 797-808
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2784412824
- Cited by
- 1,037
- References
- 40
- Citations by year
- 2026: 111 · 2025: 122 · 2024: 90 · 2023: 106 · 2022: 110 · 2021: 121 · 2020: 149 · 2019: 135 · 2018: 91
- FWCI
- 96.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- Monash University Research Portal (Monash University) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Research Repository (Kingston University London) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- National Health and Medical Research Council (1004108, 1124926)
- Health Research Council of New Zealand (12/206)
- National Institute of Health Research, United Kingdom
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Keywords
- septic shock, cortisol, mortality, mechanical ventilation, shock resolution, blood transfusion, intensive care unit, sepsis treatment, subgroup analysis, mechanical ventilation duration, vasopressor requirement, glycemic control
- MeSH terms
- Aged, Anti-Inflammatory Agents, Double-Blind Method, Female, Humans, Hydrocortisone, Infusions, Intravenous, Male, Middle Aged, Recurrence, Respiration, Artificial, Shock, Septic, Survival Rate, Fungemia, Bacteremia, Treatment Outcome, Chemotherapy, Adjuvant, Renal Replacement Therapy, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.